Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Pharmaceutics

• Publication date

  2018-02-13

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.molpharmaceut.7b00852PMID 29436232
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inner Blood-Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig.

  2017cited by this paper
• Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates.

  2017cited by this paper
• Correlation of Organic Cation/Carnitine Transporter 1 and Multidrug Resistance-Associated Protein 1 Transport Activities With Protein Expression Levels in Primary Cultured Human Tracheal, Bronchial, and Alveolar Epithelial Cells.

  2016cited by this paper
• Histology and Morphology of the Brain Subarachnoid Trabeculae

  2015cited by this paper
• Quantitative targeted absolute proteomics of rat blood–cerebrospinal fluid barrier transporters: comparison with a human specimen

  2015cited by this paper
• Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.

  2015cited by this paper
• Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood–cerebrospinal fluid barrier in human brain

  2015cited by this paper
• Utility of cerebrospinal fluid drug concentration as a surrogate for unbound brain concentration in nonhuman primates.

  2014cited by this paper
• Chronic subdural haematoma: modern management and emerging therapies

  2014cited by this paper
• Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset.

  2013cited by this paper
• Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.

  2013cited by this paper
• Drug Transporters on Arachnoid Barrier Cells Contribute to the Blood–Cerebrospinal Fluid Barrier

  2013cited by this paper
• A Clearance System for Prostaglandin D2, a Sleep-Promoting Factor, in Cerebrospinal Fluid: Role of the Blood-Cerebrospinal Barrier Transporters

  2012cited by this paper
• Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities

  2012cited by this paper
• Role of the blood–cerebrospinal fluid barrier transporter as a cerebral clearance system for prostaglandin E2 produced in the brain

  2012cited by this paper
• A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β

  2012cited by this paper
• A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain

  2012cited by this paper
• Quantitative Evaluation of the Impact of Active Efflux by P-Glycoprotein and Breast Cancer Resistance Protein at the Blood-Brain Barrier on the Predictability of the Unbound Concentrations of Drugs in the Brain Using Cerebrospinal Fluid Concentration as a Surrogate

  2011cited by this paper
• UREMIC TOXICITY OF INDOXYL SULFATE

  2010cited by this paper
• Sculpting the brain.

  2009cited by this paper
• Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid.

  2009cited by this paper
• Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria

  2008cited by this paper
• Differential expression of the multidrug resistance‐related proteins ABCb1 and ABCc1 between blood‐brain interfaces

  2008cited by this paper
• CSF as a surrogate for assessing CNS exposure: an industrial perspective.

  2008cited by this paper
• Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium.

  2008cited by this paper
• Inhibition of P-glycoprotein Activity at the Primate Blood-Brain Barrier Increases the Distribution of Nelfinavir into the Brain but Not into the Cerebrospinal Fluid

  2007cited by this paper
• Choroid plexus epithelial monolayers – a cell culture model from porcine brain

  2006cited by this paper
• Evaluation of Cerebrospinal Fluid Concentration and Plasma Free Concentration As a Surrogate Measurement for Brain Free Concentration

  2006cited by this paper
• Distinct spatio‐temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain

  2005cited by this paper
• Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier.

  2004cited by this paper
• Characterization of smooth muscle cell and pericyte differentiation in the rat retina in vivo.

  2004cited by this paper
• Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients

  2004cited by this paper
• Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics.

  2004cited by this paper
• Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus.

  2002cited by this paper
• Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1.

  2002cited by this paper
• Choroid Plexus in the Central Nervous System: Biology and Physiopathology

  2000cited by this paper
• Induction of P-glycoprotein expression in astrocytes following intracerebroventricular kainate injections

  1999cited by this paper
• Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain*

  1999cited by this paper
• Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.

  1999cited by this paper
• Pharmacokinetics of Anticancer Drugs in Cerebrospinal Fluid

  1998cited by this paper
• Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter*

  1997cited by this paper
• Ultrastructure of the human spinal arachnoid mater and dura mater.

  1996cited by this paper
• The mammalian choroid plexus.

  1989cited by this paper
• Biochemical and neurophysiological parameters in hemodialyzed patients with chronic renal failure.

  1989cited by this paper
• Saturable transport of cimetidine from cerebrospinal fluid to blood in rats.

  1985cited by this paper
• Junctions in the meninges and marginal glia

  1975cited by this paper
• Postnatal development of bulk flow in the cerebrospinal fluid system of the albino rat: clearance of carboxyl-( 14 C)inulin after intrathecal infusion.

  1973cited by this paper
• The choroid plexus: a historical review.

  1970cited by this paper
• Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

  1966cited by this paper

• Blood-brain barriers and drug pharmacokinetics: mechanisms and models.

  2025cites this paper
• Assessing central nervous system drug delivery

  2025cites this paper
• Reimagining the meninges from a neuroimmune perspective: a boundary, but not peripheral

  2024cites this paper
• Exploring Bile Acid Transporters As Key Players In Cancer Development And Treatment: Evidence From Preclinical And Clinical Studies.

  2024cites this paper
• Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics

  2024cites this paper
• Advances and controversies in meningeal biology

  2024cites this paper
• VE-cadherin in arachnoid and pia mater cells serves as a suitable landmark for in vivo imaging of CNS immune surveillance and inflammation

  2023cites this paper
• Proton-Coupled Oligopeptide Transport (Slc15) in the Brain: Past and Future Research

  2023cites this paper
• Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs

  2022cites this paper
• Novel localization of folate transport systems in the murine central nervous system

  2022cites this paper
• Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery

  2022influential citation
• A human blood–arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: Comparison with dog and pig in absolute abundance

  2022cites this paper
• Brain Distribution of Drugs: Brain Morphology, Delivery Routes, and Species Differences.

  2021cites this paper
• In Vivo Studies of Drug BBB Transport: Translational Challenges and the Role of Brain Imaging.

  2021cites this paper
• 新たな中枢関門“血液クモ膜関門”の生理学的および薬理学的な役割：新領域開拓における定量プロテオミクスの重要性

  2020cites this paper
• Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain

  2020influential citation
• Choroid plexus LAT2 and SNAT3 as partners in CSF amino acid homeostasis maintenance

  2020cites this paper
• Role of the Choroid Plexus in Health and Disease

  2020cites this paper
• Neuroprotective Mechanisms at the Blood-CSF Barrier of the Developing and Adult Brain

  2020cites this paper
• Blending Established and New Perspectives on Choroid Plexus-CSF Dynamics

  2020cites this paper
• Blood-Brain Barrier, Blood-Brain Tumor Barrier, and Fluorescence-Guided Neurosurgical Oncology: Delivering Optical Labels to Brain Tumors

  2020cites this paper
• Zidovudine and lamivudine reach higher concentrations in ventricular than in lumbar human cerebrospinal fluid.

  2020cites this paper
• Impact of P-Glycoprotein–Mediated Active Efflux on Drug Distribution into Lumbar Cerebrospinal Fluid in Nonhuman Primates

  2020cites this paper
• Brain Distribution of Drugs: Pharmacokinetic Considerations.

  2020cites this paper
• The year in review: progress in brain barriers and brain fluid research in 2018

  2019cites this paper
• ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas

  2019influential citation
• Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes

  2019influential citation
• A cellular atlas of the developing meninges reveals meningeal fibroblast diversity and function

  2019cites this paper
• Dexmedetomidine enhances glymphatic brain delivery of intrathecally administered drugs.

  2019cites this paper
• Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood-Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats.

  2019cites this paper
• Membrane Transporters Contributing to PGE2 Distribution in Central Nervous System.

  2018cites this paper
• Gene expression of A6-like subgroup of ATP-binding cassette transporters in mouse brain parenchyma and microvessels

  2018cites this paper
• Assessing central nervous system drug delivery

  year unknowncites this paper